Abstract
The lifetime risk of breast cancer may approach 80–90% in women who have germline mutations of either of two genes, BRCA1 or BRCA2 (refs. 1–3). A single BRCA1 mutation, 185delAG, has been noted in approximately 20% of Ashkenazi Jewish women with early onset breast cancer and in 0.9% of the Ashkenazi population4–6. We recently detected a 6174delT frameshift mutation in BRCA2 in an hereditary breast cancer kindred of Ashkenazi Jewish ancestry. Here, we investigated the frequency of this mutation in 200 women with early-onset breast cancer. Six of 80 Ashkenazi Jewish women (8%) diagnosed with breast cancer before the age of 42, were heterozygous for the 6174delT mutation, compared to none of 93 non-Jewish women diagnosed with breast cancer at the same age (P = .005). These cases were ascertained without regard to family history. Two of 27 (7%) additional Jewish families in which the proband was diagnosed with breast cancer at age 42 to 50 and had a family history of breast or ovarian cancer had germline 6174delT mutations. The results of this report suggest that a recurrent mutation of BRCA1 and a recurrent mutation of BRCA2 together may account for over a quarter of all early-onset breast cancer cases and two thirds of early-onset breast cancer in the setting of a personal or family history of ovarian cancer in Ashkenazi Jewish women.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Easton, D. et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet. 52, 678–701 (1993).
Wooster, R. et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265, 2088–2090 (1994).
Miki, Y. et al. A strong candidate gene for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Struewing, J.P. et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet. 11, 198–200 (1995).
FitzGerald, M.G. et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N. Engl. J. Med. 334, 143–149 (1996).
Offit, K. et al. Germline BRCA1 185delAG mutations in Jewish women affected by breast cancer. Lancet (in the press).
Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789–792 (1995).
Tavtigian, S.V. et al. The BRCA2 gene and mutations in 13q-linked kindreds. Nature Genet. 12, 333–337 (1996).
Langston, A.A. et al. BRCA1 mutations in a population-based sample of young women with early-onset breast cancer. N. Engl. J. Med. 334, 137–142 (1996).
Offit, K. & Brown, K. Quantitative risk counseling for familial cancer: a resource for clinical oncologists. J. Clin. Oncol. 12, 1724–1736 (1994).
Saiki, R.K. et al. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230, 1350–1354 (1985).
Mullis, K. et al. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor Symp. Quant. Biol. 51, 263–273 (1986).
Weber, J.L. & May, P.E. Abundant class of human DNA polymorphism which can be typed using the polymerase chain reaction. Am. J. Hum. Genet. 44, 388–96 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neuhausen, S., Gilewski, T., Norton, L. et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 13, 126–128 (1996). https://doi.org/10.1038/ng0596-126
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0596-126
This article is cited by
-
Correlation between family history and characteristics of breast cancer
Scientific Reports (2021)
-
Simulation modeling for stratified breast cancer screening – a systematic review of cost and quality of life assumptions
BMC Health Services Research (2017)
-
Family history predictors of BRCA1/BRCA2 mutation status among Tunisian breast/ovarian cancer families
Breast Cancer (2017)
-
The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance
Breast Cancer Research (2016)
-
To Reflex or Not: Additional BRCA1/2 Testing in Ashkenazi Jewish Individuals Without Founder Mutations
Journal of Genetic Counseling (2015)